Stock Report

Dr. Reddy's Laboratories updates on PAI of formulations facility



Posted On : 2022-07-07 21:01:24( TIMEZONE : IST )

Dr. Reddy's Laboratories updates on PAI of formulations facility

The United States Food & Drug Administration (USFDA) today completed a PreApproval Inspection (PAI) at its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh. The inspection was conducted from 30th June, 2022 to 7th July, 2022. We have been issued a Form 483 with two observations, which we will address within the stipulated timeline.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4338.35 as compared to the previous close of Rs. 4393.80. The total number of shares traded during the day was 6730 in over 1634 trades.

The stock hit an intraday high of Rs. 4443.00 and intraday low of 4330.00. The net turnover during the day was Rs. 29418868.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 RDY USFDA PreApprovalInspection FormulationsFacility Srikakulam